Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
NOVELIX THERAPEUTICS GMBH
| NOVELIX THERAPEUTICS GMBH Patent applications | ||
| Patent application number | Title | Published |
|---|---|---|
| 20100034816 | Treatment of Diabetes by at Least One Epidermal Growth Factor Receptor Specific Antibody or a Derivative Thereof - The present invention relates to the use of at least one epidermal growth factor receptor specific antibody or a derivative thereof for the manufacture of a medicament for the treatment of diabetes, in particular of the advanced insulin-dependent stage of diabetes mellitus Type 1 and 2 in humans as well as in animals. | 02-11-2010 |